Christine Wu Nordahl is professor of psychiatry and behavioral sciences at the University of California, Davis MIND Institute.
Christine Wu Nordahl
Assistant professor
University of California, Davis
From this contributor
Early brain enlargement augurs distinct form of autism
A minority of boys with autism have brains that are unusually large relative to their bodies — a trait tied to regression and intellectual disability.
Early brain enlargement augurs distinct form of autism
By
Christine Wu Nordahl
11 April 2017 | 5 min read
Questions for Nordahl, Mello: Scans for children with autism
Techniques used in behavioral interventions could help scientists scan the brains of children who have both autism and intellectual disability.
Questions for Nordahl, Mello: Scans for children with autism
By
Jessica Wright
19 July 2016 | 6 min read
Charting typical brain development
How can we characterize what is atypical when we don’t fully understand what typical brain development looks like, particularly under the age of 5? Christine Wu Nordahl explains the importance of scanning the brains of typically developing children.
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read